Institutional Ownership Tarsus Pharmaceuticals, Inc. (TARS)
This table provides information about the institutional ownership of Tarsus Pharmaceuticals, Inc. (TARS). We have compiled data on the 215 institutions that hold shares in the stock, with a total of 46.3 Million shares, which have been reported (via 13F filing form) to have a value of $2.28 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
445,758
shares
|
$22 Million
0.07% of portfolio
|
Q3 2022
Added 10.68%
|
|
|
Clearbridge Investments, LLC
New York, NY |
Aug 12, 2025 Q2 2025 |
444,502
shares
|
$21.9 Million
0.02% of portfolio
|
Q2 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
397,994
shares
|
$19.6 Million
0.0% of portfolio
|
Q2 2025
Added 32.0%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
383,902
shares
|
$18.9 Million
0.0% of portfolio
|
Q2 2025
Reduced 11.37%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
373,750
shares
|
$18.4 Million
1.03% of portfolio
|
Q2 2025
Added 5.47%
|
|
|
J. Goldman & CO LP
New York, NY |
Aug 14, 2025 Q2 2025 |
364,557
shares
|
$18 Million
0.39% of portfolio
|
Q2 2025
Added 159.86%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
357,178
shares
|
$17.6 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.72%
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
350,000
shares
|
$17.3 Million
4.31% of portfolio
|
Q3 2024
Added 48.94%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
341,496
shares
|
$16.9 Million
2.71% of portfolio
|
Q2 2025
New holding
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
336,939
shares
|
$16.6 Million
0.0% of portfolio
|
Q2 2025
Added 27.38%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
329,297
shares
|
$16.3 Million
0.0% of portfolio
|
Q1 2025
Reduced 11.84%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Aug 14, 2025 Q2 2025 |
300,000
shares
|
$14.8 Million
1.23% of portfolio
|
Q2 2025
Reduced 25.0%
|
|
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
Aug 14, 2025 Q2 2025 |
250,000
shares
|
$12.3 Million
2.56% of portfolio
|
Q2 2025
Added 40.08%
|
|
|
Capitolis Liquid Global Markets LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
242,100
shares
|
$12 Million
0.07% of portfolio
|
Q2 2025
New holding
|
|
|
Jump Financial, LLC
Chicago, IL |
Aug 13, 2025 Q2 2025 |
237,117
shares
|
$11.7 Million
0.12% of portfolio
|
Q2 2025
Added 385.9%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
229,246
shares
|
$11.3 Million
0.0% of portfolio
|
Q2 2025
Reduced 76.91%
|
|
|
Integral Health Asset Management, LLC
|
Aug 14, 2025 Q2 2025 |
200,000
shares
|
$9.87 Million
0.82% of portfolio
|
Q1 2025
Reduced 42.86%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
197,900
shares
|
$9.77 Million
0.29% of portfolio
|
Q2 2025
Reduced 69.73%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Aug 14, 2025 Q2 2025 |
196,536
shares
|
$9.7 Million
2.43% of portfolio
|
Q2 2025
Reduced 59.48%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
189,551
shares
|
$9.36 Million
0.0% of portfolio
|
Q2 2025
Added 6054.25%
|
|
|
Prudential Financial Inc
Newark, NJ |
Aug 12, 2025 Q2 2025 |
182,400
shares
|
$9 Million
0.01% of portfolio
|
Q2 2025
Added 50.99%
|
|
|
Tri Locum Partners LP
New York, NY |
Aug 14, 2025 Q2 2025 |
177,656
shares
|
$8.77 Million
2.59% of portfolio
|
Q2 2025
New holding
|
|
|
Sands Capital Ventures, LLC
Arlington, VA |
Aug 13, 2025 Q2 2025 |
170,000
shares
|
$8.39 Million
2.22% of portfolio
|
Q1 2024
Reduced 34.62%
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Aug 12, 2025 Q2 2025 |
162,996
shares
|
$8.05 Million
0.06% of portfolio
|
Q2 2025
Added 106.83%
|
|
|
Russell Investments Group, Ltd.
|
Aug 13, 2025 Q2 2025 |
145,240
shares
|
$7.17 Million
0.01% of portfolio
|
Q2 2025
Added 7.89%
|